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ABSTRACT 
Objective: This study was undertaken to determine the sero- 
epidemiology of Hantavirus infection in the Philippines. 
Methods: This is a cross-sectional study done in asymptomatic 
volunteers from various communities in the Philippines selected 
by a stratified multistage sampling design. Antibody to Han- 
&virus was detected by particle agglutination (PA) test using 
Hantadia high-density particle agglutination (HDPA) reagent kit. 
Results: The prevalence of positive Hantavirus antibody among 
461 subjects was the same in both males (6.1%) and females 
(6.1%) in rural (7.6%), urban (5.6%) and urban poor (5.1%) 
populations. 
Conclusions: The prevalence of Hantavirus infection in the Fil- 
ipino population is comparable to that seen in other develop- 
ing countries. The HDPA can be conveniently used as a rapid 
tool to detect the Hantavirus antibody for seroepidemiologic 
and diagnostic purposes. 
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In 1982, the World Health Organization (WHO) recom- 
mended naming the syndrome caused by Hantaan virus 
and other Hantaviruses as “hemorrhagic fever with renal 
syndrome” (HFRS),’ because of the nephropathy associ- 
ated with the disease heralded by an abrupt high-grade 
fever with hemorrhagic manifestations. This was first rec- 
ognized in an epidemic among Korean soldiers in 1951 
and was initially called Korean hemorrhagic fever (KHF).’ 
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Outbreaks of what is believed to have been HFRS in Rus- 
sia, Manchuria, and Sweden, as early as 1913 and 1932, 
have been described.’ In 1976, Professor Ho Wang Lee 
and co-workers detected antigens in the lung tissues of 
73 rodents (Apodemus agrurius coreae).2 Conversely, 
antibodies against these antigens were noted in conva- 
lescent-phase sera from patients with ME The agent, 
named after Hantaan River in Korea where it was first 
detected, belongs to the newly established genus Hun- 
tar&us of the family Bunyaviridae. There are many 
serotypes, including Hantaan virus, Belgrade or Dobrava 
virus, Seoul virus, Puumala virus, and Sin Nombre virus. 
Varying degrees of severity and outcome are associ- 
ated with the different serotypes, which occur in spe- 
cific geographic locations of the world.’ The Puumala 
virus causes mild disease in Europe, Russia, and Scandi- 
navia, whereas the Seoul virus causes moderate disease 
worldwide. A severe form of HFRS is caused by Hantaan 
virus in China, Russia, and Korea and by the Belgrade or 
Dobrava virus in the Balkan countries. Currently, there is 
an expanding list of emerging serotypes worldwide. In 
one geographic location, as many as three Huntuvirus 
serotypes may be present. 
The spectrum of HFRS ranges from fever or flu-like 
symptoms and albuminuria alone to fatal disease. Those 
with severe disease initially present with a febrile phase, 
followed by subsequent phases of hypotension, oliguria, 
diuresis, and convalescence.4 Intractable shock leading 
to death may ensue during the hypotensive phase if sup- 
portive measures are delayed or inadequate. Fatal cases 
of adult respiratory distress of unknown origin occurred 
in the United States in 1993 and were eventually dis- 
covered to have been caused by a Hantavirus serotype, 
specifically the Sin nombre virus. 
Seroepidemiologic surveys worldwide among 
rodents, which are the most commonly identified reser- 
voirs of Hantaviruses, and among both symptomatic and 
asymptomatic humans have established Huntavirus 
infection in different locations. Hantavirus is said to be 
focally enzootic in nine countries in Asia: Japan, South 
Korea, North Korea, China, Mongolia, Russia, Hong Kong, 
Malaysia, and Sri Lanka, and in 17 countries in Europe: 
Russia, Finland, Sweden, Norway, Denmark, Bulgaria, Hun- 
gary, Albania, Germany, France, Belgium, Netherlands, 
Switzerland, England, Yugoslavia, Greece, and Central 
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African Republic.3,5 Studies among asymptomatic indi- 
viduals in the general population have shown a preva- 
lence of positive antibody to Hantaviruses of 8.9% in 
northern Sweden,” 6.2% in Central Africa,’ 6.2% in Tai- 
wan,” 2.7% in Argentina, Uruguay, and Bolivia,? 1.7% in 
Germany, lo and 1.4% in Canada. l1 The Philippines is one 
of the 10 countries known to have urban rats infected 
with Hantaviruses, specifically the Seoul virus serotype.” 
Serologic detection of Hantavirus antibody by either 
immunofluorescent assay (IFA), or enzyme-linked 
immunosorbent assay (ELlSA), previously has been used 
in seroepidemiologic surveys in other countries. More 
recently, a particle agglutination test using high-density 
particles (HDP) has been developed by Lee and Tomiyama 
for the rapid detection of antibodies to Hantaan and 
Puumala virus in the serum. l3 The HDP that are made of 
newly developed silica carriers primarily are used to elim- 
mate chances of nonspecific agglutination. They are supe- 
rior to erythrocyte carriers and are produced on the basis 
of the latest technology in polymer or inorganic colloid 
chemistry. The HDP have higher specific gravity than ery- 
throcytes, have good uniformity in particle diameter, are 
deeply colored with dyes, and have surface properties that 
are suitable for coating with a variety of immunologic sub 
stances, such as proteins, lipids, and polysaccharides. Most 
significantly, they do not demonstrate nonspecific anti- 
genicity. The sensitized HDPs absorbed with the Hantaan 
virus antigen are agglutinated specifically in the presence 
of antibody to this antigen in the serum tested, although 
cross-reactions with other serotypes may occur. In com- 
parison with previously reported test procedures, such as 
IFA and ELISA, this test is simple, rapid, and said to have 
high sensitivity and specificity rates. 
Using this particle agglutination test with HDP this 
study was done to document the seroepidemiologic 
prevalence of antibodies against Hantaan virus and cross- 
reacting Hantavirus serotypes among asymptomatic Fil- 
ipino subjects from rural, urban, and urban poor areas in 
the Philippines. The prevalence of positive antibodies to 
Hantavirus was compared among residents from these 
three areas, among males and females, and among differ- 
ent age groups. 
MATERIALS AND METHODS 
Subjects 
The survey was undertaken using a subsample of the 
population selected for the 1997 tuberculosis prevalence 
survey conducted nationwide and in the urban poor set- 
tlements in the Philippines.14J5 Population selection was 
by a stratified multistage sampling design previously 
described. 14,15 For urban or rural classification of the var- 
ious villages in the sampling frame, the categorization 
was based on the National Statistics Office (NSO) classi- 
fication adapted in the Philippines in 1990. 
Among 2 1 rural, 15 urban, and 12 urban poor clus- 
ters selected for the tuberculosis survey, 8,7, and 3 clus- 
ters, respectively, were included in the seroprevalence 
survey for Hantavirus antibody Of the rural clusters, four 
were in Luzon, three in the Visayas, and one in Mindanao. 
The urban clusters comprised six in Luzon, and one in 
Mindanao, and the urban poor clusters comprised two 
in Metro Manila and one in Metro Cebu. Subjects in these 
clusters who agreed to participate in the study were 
included. After informed consent, blood was drawn from 
these individuals. 
Serologic Test 
Antibody to Hantaan virus and cross-reacting Hantavirus 
serotypes was detected by particle agglutination (PA) test 
using Hantadia HDPA reagent kit (Korean Green Cross 
Corp., Seoul, Korea) provided by Vizcarra Pharmaceuti- 
cals, Manila, Philippines. 
The serum samples were tested in parallel with 
lyophilized unsensitized control HDI? Both reagents were 
reconstituted with 0.55 mL of HDP diluent 30 minutes 
before use. This diluent consisted of 3 mL phosphate 
buffer, 0.5% (w/v) bovine serum albumin (United States 
Pharmacopeia), and 3 mg sodium azide. 
Blood was allowed to clot, and serum was collected 
in cryogenic vials and transported in dry ice or coolant 
to the laboratory If the serum showed some erythrocytes 
or other visible components, the sample was centrifuged 
at 1500 i-pm for 10 minutes, until clear, to remove parti- 
cles that may interfere with the test. Serum samples were 
diluted at 1:40 using 10 p,L serum to 400 FL serum dilu- 
ent consisting of 18 mL phosphate buffer with 1% (w/v) 
bovine serum albumin and 18 mg sodium azide. A posi- 
tive serum control consisting of 0.5 mL lyophilized goat 
anti-Hantaan virus serum with 0.5 mg sodium azide was 
used. A negative serum control consisting of the serum 
diluent was run with the test. 
Serum samples in equal volumes of 25 PL and the 
positive and negative serum controls were dispensed in 
two wells each in the microtiter plates. Hantaan virus 
antigen sensitized HDP (liquid) was added in one well 
and unsensitized control HDP (liquid) was added in the 
other well. The HDP reagents were thoroughly shaken 
before use, to obtain a homogeneous solution. The trays 
were placed on a microplate mixer for about 10 seconds 
and then allowed to stand at room temperature for 1 
hour or overnight covered with a glass plate, to prevent 
evaporation of reagents. 
Tests were read as qualitatively positive if there was 
a red ring at the bottom of the well with numerous 
peripheral agglutinates when viewed against a light 
source. A negative test showed a compact button in the 
center of the well with a smooth round outer margin. 
If the test serum gave a negative result with control 
HDP and at the same time a negative result with Hantaan 
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Characteristic 
Gender 
Male Female 
Age (Y) 
20-39 
40-59 
260 
Unknown 
Table 1. Demographic Characteristics of Subjects in the Rural, Urban, and Urban Poor Clusters 
Rural Urban Urban Poor Total 
n = 131(100%) n = 232 (100%) n = 98 (100%) n = 467 (700%) 
41 (31) 90 (39) 34 (35) 165 90 (69) (36) 142 61
64 (65) 296 (64) 
31 (24) 60 (26) 41 132 (42) (29) 
51 (39) 107 (46) 34 192 (35) 
(14) 
(42) 
19 65 (28) 15 (15) 99 
30 (23) 
(21) 
8 (8) 38 (8) 
virus antigen sensitized HDP, it was judged negative. If 
the test serum gave a negative result with control HDP 
and a positive test with Hantaan virus antigen sensitized 
HDP it was judged positive. If the test serum gave a pos- 
itive result with control HDP and at the same time with 
Hantaan virus antigen sensitized HDP absorption was 
done and the test was repeated. If the test serum gave a 
positive result with control HDP and a negative result 
with Hantaan virus antigen sensitized HDP, it was 
regarded as a test error and judged negative. 
RESULTS 
The subjects included in this study comprised 499 volun- 
teers from 18 different clusters in the Philippines, specifi- 
cally from eight rural, seven urban, and three urban poor 
areas, of which five, five, and two areas, respectively, had 
at least one individual positive for Hantavirus antibody 
Of the 499 blood samples, 33 were hemolyzed upon 
receipt in the laboratory and discarded. The remaining 466 
were tested for antibody to Hantavirus by particle agglu- 
tination. Five volunteers, aged 12,13,16,18, and 19 years, 
arc not included in the data description and analysis. 
Table 1 shows the demographic characteristics of 
the 461 patients tested by area of residence. There were 
more females than males in the population surveyed; this 
was true in all areas studied. The majority of those sur- 
veyed were in the age group 40 to 59 years, except in the 
urban poor clusters, where the age group 20 to 29 years 
was predominant. 
Table 2 shows the prevalence of positive Hantavims 
antibody according to gender, age, and area of residence. 
Among the 461 patients tested, 28 (6.1%) demonstrated 
positive Hantavirus antibody The prevalence of positive 
Hantavirus antibody was the same in males (10/165, 
6.1%) and females (18/296,6.1%). 
Hantavims antibody was positive in 6 (4.6%) of 132 
in the age group 20 to 39 years, 14 (7.3%) of 192 in the age 
group 40 to 59 years, and 6 (6.1%) in 99 in the age group 
60 years or older. There was no information on age for 38 
individu&, 2 (5.3%) of whom had positive Hantavims anti- 
body. There was no statistically significant difference in the 
prevalence among the age groups (P = 0.781). 
Ten (7.6%) of the 131 subjects from rural, 13 (5.6%) 
of the 232 from urban, and 5 (5.1%) of 98 from urban 
poor areas were positive for Hantavirus antibody. 
There was no statistical significance among the preva- 
lence rates in the rural, urban, and urban poor populations 
(P = 0.517). 
DISCUSSION 
The availability of serodiagnostic methods for the detec- 
tion of Hantavims antibody has facilitated the detection 
of Hantavirus infection in several areas worldwide, even 
among unsuspected populations. Results from various 
serologic studies done in different locations has con- 
tributed to knowledge on the geographic distribution of 
this group of viruses. The data from this study provide 
substantial evidence that Hantavirus infection does 
occur in the Philippines. Although there has as yet been 
no documented case of HFRS among Filipino patients, 
the detection of antibody to Hantavirus among the 
asymptomatic subjects in this study should increase 
awareness of this disease. In countries like the Philip- 
pines where diseases resembling HFRS, such as dengue 
fever and leptospirosis, are highly prevalent, Hantavirus 
should be a differential diagnosis in patients with acute 
febrile illness, particularly those with renal impairment. 
Cross-reactions among serotypes have been re- 
ported. M-M In a study by Lee and van der Groen, it was 
reported that, in the Philippines, urban rats harbor Seoul 
Table 2. Prevalence of Positive Hantavirus Antibody 
according to Gender, Age, and Area of Residence 
Characteristic Positive Hantavirus Antibody Total Tested 
n=28 (6.1%) n = 461 
Gender (P = 0.856) 
Male 10 6.1 165 
Female 18 6.1 296 
Age (y) (P = 0.781) 
20-39 6 4.6 132 
40-59 14 7.3 192 
2 60 6 6.1 99 
Unknown age 2 5.3 38 
Residence (P = 0.517) 
Rural 10 7.6 131 
Urban 13 5.6 232 
Urban poor 5 5.1 98 
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virus antibody.‘* The HDPA kit that was used in the 28 
volunteers who tested positive ln this study is reported 
to detect Hantaan and Puumala viruses. It is possible that 
due to cross-reactivity, antibodies to different serotypes 
may have been detected by HDPA, and the same serotype 
actually circulates in both rodents and humans. It is likely 
that more than one serotype exists in the Philippines that 
cross-react with one another. 
Hemorrhagic fever with renal syndrome was thought 
to occur only in the rural areas, with farmers and soldiers 
at risk because of their exposure to field rats. However, 
subsequent Hantavirus outbreaks have occurred among 
urban dwellers as well as among laboratory personnel 
handling experimental rodents. Other groups at risk 
include hunters, campers, rodent breeders, telephone line 
workers, and construction ground workers. Three epi- 
demiologic patterns have been recognized based on the 
location of the outbreak and the reservoir host*: (1) the 
rural type, with field rats as the reservoirs; (2) the urban 
type, with house rats as reservoirs; and (3) the animal 
room type, with experimental rats as reservoirs. 
In the present study, no significant difference in the 
prevalence of Hantavirus antibody in the various age 
groups, in males and females, or in residence, whether 
urban or rural, was observed. This finding may be attrib- 
uted either to sampling error, as the volunteers were not 
representative of the strata tested, or to the inherent lim- 
itation of the HDPA kit, which may not have actually 
been of high specificity. The prevalence of positive anti- 
body of 6.1% among 461 asymptomatic volunteers in 
the Philippines compares with that of Central Africa 
(6.2%) and Taiwan (6.2%).‘~‘” However, because of a prob- 
able sampling error, the data cannot be extrapolated to 
the entire population. Seroepidemiologic studies on a 
randomly selected sample from the general population 
would better define the true prevalence of Hantavirus 
infection, and studies on human HFRS will allow 
researchers to define the disease spectrum in Filipino 
patients. Furthermore, rodent testing with reverse tran- 
scriptase polymerase chain reaction (RI’-PCR) of tissues 
from seropositive rodents also may help clarify the pos- 
sible presence of multiple serotypes in the Philippines. 
In addition, more studies on the HDPA kit should be 
done to validate its specificity and determine its cost- 
effectiveness as a rapid serologic test for Hantavirus 
serotypes. 
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